2748522-40-7
2748522-40-7
Chemical Structure
Ketotifen-13C,d3
- CAS No.: 2748522-40-7
- Formula:C1813CH16D3NOS
- Molecular Weight:313.44
IUPAC Name: 4-(1-(methyl-13C-d3)piperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one
InChIKey: ZCVMWBYGMWKGHF-KQORAOOSSA-N
SMILES: O=C(C1=C/2C=CS1)CC3=CC=CC=C3C2=C4CCN([13C]([2H])([2H])[2H])CC/4
Biological Activity: Ketotifen-13C,d3 is deuterium labeled Ketotifen.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ketotifen-13C,d3 | Ketotifen-13C,d3 is deuterium labeled Ketotifen. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ketotifen (Standard) | ≥98% | Ketotifen (Standard) is the analytical standard of Ketotifen. This product is intended for research and analytical applications. Ketotifen (HC 20-511) is an orally active second-generation noncompetitive histamine 1 (H1) receptor blocker and mast cell stabilizer. Ketotifen can block 6-phosphogluconate dehydrogenase (PGD) in vitro. Ketotifen also has antiviral activity against SARS-CoV-2 and Influenza virus. Ketotifen can be used to the research of autoimmune encephalomyelitis (EAE) and asthma attack prevention. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ketotifen-d3 | Ketotifen-d3 (HC 20-511-d3) is deuterium labeled Ketotifen. Ketotifen (HC 20-511) is an orally active second-generation noncompetitive histamine 1 (H1) receptor blocker and mast cell stabilizer. Ketotifen can block 6-phosphogluconate dehydrogenase (PGD) in vitro. Ketotifen also has antiviral activity against SARS-CoV-2 and Influenza virus. Ketotifen can be used to the research of autoimmune encephalomyelitis (EAE) and asthma attack prevention. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ketotifen | 99.94% | Ketotifen (HC 20-511) is an orally active second-generation noncompetitive histamine 1 (H1) receptor blocker and mast cell stabilizer. Ketotifen can block 6-phosphogluconate dehydrogenase (PGD) in vitro. Ketotifen also has antiviral activity against SARS-CoV-2 and Influenza virus. Ketotifen can be used to the research of autoimmune encephalomyelitis (EAE) and asthma attack prevention. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
